Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if applying an anesthetic topical adhesive, Synera®, will
reduce the injection pain. Relieving injection site pain may improve the tolerability of
Multiple Sclerosis medications.
Study Hypothesis: Pre-medication with Synera will have a significant effect on pain ratings
as measured by the visual analog scale and Local injection site reaction scale.
Phase:
Phase 4
Details
Lead Sponsor:
Brown, Theodore R., M.D., MPH
Treatments:
Anesthetics Anesthetics, Local Glatiramer Acetate Interferon-beta